O'Brien P Q, Williams B T, Chen K W. "一种环戊二烯铊(I)的合成方法" [P]. US Patent, US 9242599 B2, 2022-10-09.
发明人冯建国,高志强,陈志强. "Method for the Synthesis of 34822-90-7
Cyclopentadienylthallium
Thallium, pi-cyclopentadienyl- (8CI)
Thallium, (eta5-2,4-cyclopentadien-1-yl)- (9CI)
Thallium, (eta5-2,4-cyclopentadien-1-yl)-
EINECS 252-229-2
NSC 114719
Thallium cyclopentadienide
Thallous cyclopentadienide" [P]. 中国发明专利, 专利号 CN 113052643 A, 授权公告日 2015-01-02.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 环戊二烯铊(I) in Pharmaceutical Formulations". J. Nat. Prod., 2015, 529, (3), 7021-7025.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 环戊二烯铊(I) as an Impurity". Chromatographia, 2010, 2219, (8), 4604-4626.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 34822-90-7
Cyclopentadienylthallium
Thallium, pi-cyclopentadienyl- (8CI)
Thallium, (eta5-2,4-cyclopentadien-1-yl)- (9CI)
Thallium, (eta5-2,4-cyclopentadien-1-yl)-
EINECS 252-229-2
NSC 114719
Thallium cyclopentadienide
Thallous cyclopentadienide Using HRMS and NMR". J. Pharm. Biomed. Anal., 2015, 402, 638-643.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 环戊二烯铊(I) Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2021, 2158, 6465-6495.